CN101757203A - Medicament for treating hepatitis - Google Patents
Medicament for treating hepatitis Download PDFInfo
- Publication number
- CN101757203A CN101757203A CN201010106588A CN201010106588A CN101757203A CN 101757203 A CN101757203 A CN 101757203A CN 201010106588 A CN201010106588 A CN 201010106588A CN 201010106588 A CN201010106588 A CN 201010106588A CN 101757203 A CN101757203 A CN 101757203A
- Authority
- CN
- China
- Prior art keywords
- medicine
- radix
- melanteritum
- mel
- fructus jujubae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicament for treating hepatitis, used for restoring damaged hepatic cells to reach the purpose of treating the hepatitis. The medicament has dosage forms of decoctions, medicinal granules, pills, medicinal extracts and powders and comprises the following raw materials in proportion: 15-20g of atractylodes, 20-25g of artemisia capillaries, 15-20g of dried green orange peel, 10-20g of polyporus, 10-15g of ricepaper pith and 10-15g of glycyrrhiza.
Description
Technical field
The present invention relates to medical technical field, relate in particular to a kind of medicine for the treatment of hepatitis.
Background technology
Hepatitis is the inflammation of liver, and people health in serious harm.Because hepatitis is of a great variety, morbific cause of disease complexity, as in time treatment or therapeutic effect are not good, the state of an illness will worsen.
At present, medically to the treatment of hepatitis, especially the treatment of hepatitis B etc., what mainly adopt is antiviral therapy, because antiviral therapy has its clear and definite indication and contraindication, and the influence that is subjected to aspect reasons such as economic condition, the patient that can receive regular antiviral therapy at present is also more limited, stops further developing of disease so Most patients can only protect the liver by antiinflammatory.
Summary of the invention
Main purpose of the present invention is to provide a kind of medicine for the treatment of hepatitis, to be used to repair the hepatocyte of damage, reaches the purpose of treatment hepatitis.
The invention provides a kind of medicine for the treatment of hepatitis, its dosage form comprises decoction, electuary, pill, unguentum, powder, is mainly made by following proportion raw material:
The Rhizoma Atractylodis Macrocephalae 15～20g: Herba Artemisiae Scopariae 20～25g: Pericarpium Citri Reticulatae Viride 15～20g: Polyporus 10～20g: Medulla Tetrapanacis 10～15g: Radix Glycyrrhizae 10～15g.
Preferable, this medicine can also add adjuvant in the following manner:
Mode one, add in above-mentioned major ingredient and comprise Melanteritum, Fructus Jujubae and Mel, each proportion of raw materials is as follows:
The Rhizoma Atractylodis Macrocephalae 15～20g: Herba Artemisiae Scopariae 20～25g: Pericarpium Citri Reticulatae Viride 15～20g: Polyporus 10～20g: Medulla Tetrapanacis 10～15g: Radix Glycyrrhizae 10～15g: Melanteritum 5～8g: the Fructus Jujubae 5～8g after doing is fried in enucleation: Mel 5～8g.Among the present invention, the preparation of this medicine and instructions of taking can be to make decoction to the Rhizoma Atractylodis Macrocephalae, Herba Artemisiae Scopariae, Pericarpium Citri Reticulatae Viride, Polyporus, Medulla Tetrapanacis, Radix Glycyrrhizae are added decocting by said ratio, and Melanteritum, Fructus Jujubae, Mel are made pill by said ratio.When taking, decoction and pill that above-mentioned weight portion is made are divided into three parts, once take a decoction and pill, and three times on the one, and decoction and pill are taken simultaneously.Perhaps be prepared as follows:
With the Rhizoma Atractylodis Macrocephalae 15～20g: Herba Artemisiae Scopariae 20～25g: Pericarpium Citri Reticulatae Viride 15～20g: Polyporus 10～20g: Medulla Tetrapanacis 10～15g: Radix Glycyrrhizae 10～15g decocts with water; In decocting the concentrated solution that after-filtration goes out, allocate Melanteritum 5～8g, enucleation then into and fry Fructus Jujubae 5～8g after doing, and Mel 5～8g mf mass pil.
Mode two, add Radix Gentianae, Radix Ophiopogonis and Spora Lygodii in above-mentioned major ingredient, each proportion of raw materials is as follows:
The Rhizoma Atractylodis Macrocephalae 15～20g: Herba Artemisiae Scopariae 20～25g: Pericarpium Citri Reticulatae Viride 15～20g: Polyporus 10～20g: Medulla Tetrapanacis 10～15g: Radix Glycyrrhizae 10～15g: Radix Gentianae 10～15g: Radix Ophiopogonis 6～10g: Spora Lygodii 10～15g.
Mode three, add Melanteritum, Fructus Jujubae, Mel, Radix Gentianae, Radix Ophiopogonis and Spora Lygodii in above-mentioned major ingredient, each proportion of raw materials is as follows:
The Rhizoma Atractylodis Macrocephalae 15～20g: Herba Artemisiae Scopariae 20～25g: Pericarpium Citri Reticulatae Viride 15～20g: Polyporus 10～20g: Medulla Tetrapanacis 10～15g: Radix Glycyrrhizae 10～15g: Radix Gentianae 10～15g: Radix Ophiopogonis 6～10g: Spora Lygodii 10～15g: Melanteritum 5～8g: the Fructus Jujubae 5～8g after doing is fried in enucleation: Mel 5～8g.
Among the present invention, the preparation method of the medicine of above-mentioned treatment hepatitis can be that major ingredient and one of adjuvant are adopted traditional technology refining, also can be that major ingredient and adjuvant are separately refined and taken simultaneously with decoction and pill respectively.Three describe for example in the above described manner:
The preparation of this medicine and instructions of taking can be to add decocting to the just Rhizoma Atractylodis Macrocephalae, Herba Artemisiae Scopariae, Pericarpium Citri Reticulatae Viride, Polyporus, Medulla Tetrapanacis, Radix Glycyrrhizae, Radix Gentianae, Radix Ophiopogonis and Spora Lygodii by said ratio to make decoction, and Melanteritum, Fructus Jujubae, Mel are made pill by said ratio; When taking, decoction and pill that above-mentioned weight portion is made are divided into three parts, once take a decoction and pill, and three times on the one, and decoction and pill are taken simultaneously.Perhaps be prepared as follows:
With the Rhizoma Atractylodis Macrocephalae 15～20g, Herba Artemisiae Scopariae 20～25g, Pericarpium Citri Reticulatae Viride 15～20g, Polyporus 10～20g, Medulla Tetrapanacis 10～15g, Radix Glycyrrhizae 10～15g, Radix Gentianae 10～15g, Radix Ophiopogonis 6～10 and Spora Lygodii 10～15g decoct with water;
In decocting the concentrated solution that after-filtration goes out, allocate Melanteritum 5～8g, enucleation into and fry Fructus Jujubae 5～8g after doing, and Mel 5～8g mf mass pil.
Said medicine can be repaired the hepatocyte of damage, and to hepatitis, especially hepatitis B, icterohepatitis and liver cirrhosis are had the obvious treatment effect.
The present invention also provides a kind of medicine for the treatment of hepatitis, and its dosage form comprises decoction, electuary, pill, unguentum, powder, is mainly made by following proportion raw material:
Melanteritum 5～8g: the Fructus Jujubae 5～8g after doing is fried in enucleation: Mel 5～8g.
Preferable, this medicine can also add adjuvant in the following manner:
Mode one, add the Rhizoma Atractylodis Macrocephalae, Herba Artemisiae Scopariae, Pericarpium Citri Reticulatae Viride, Polyporus, Medulla Tetrapanacis and Radix Glycyrrhizae in this major ingredient, each proportion of raw materials is as follows: Melanteritum 5～8g: the Fructus Jujubae 5～8g after doing is fried in enucleation: Mel 5～8g: the Rhizoma Atractylodis Macrocephalae 15～20g: Herba Artemisiae Scopariae 20～25g: Pericarpium Citri Reticulatae Viride 15～20g: Polyporus 10～20g: Medulla Tetrapanacis 10～15g: Radix Glycyrrhizae 10～15g.
Mode two, add Melanteritum, Fructus Jujubae, Mel, Radix Gentianae, Radix Ophiopogonis and Spora Lygodii in above-mentioned major ingredient, each proportion of raw materials is as follows: Melanteritum 5～8g: the Fructus Jujubae 5～8g after doing is fried in enucleation: Mel 5～8g: the Rhizoma Atractylodis Macrocephalae 15～20g: Herba Artemisiae Scopariae 20～25g: Pericarpium Citri Reticulatae Viride 15～20g: Polyporus 10～20g: Medulla Tetrapanacis 10～15g: Radix Glycyrrhizae 10～15g: Radix Gentianae 10～15g: Radix Ophiopogonis 6～10g: Spora Lygodii 10～15g.
Mode three, add Radix Gentianae, Radix Ophiopogonis and Spora Lygodii in above-mentioned major ingredient, each proportion of raw materials is as follows: Melanteritum 5～8g: the Fructus Jujubae 5～8g after doing is fried in enucleation: Mel 5～8g: Radix Gentianae 10～15g: Radix Ophiopogonis 6～10g: Spora Lygodii 10～15g.
Among the present invention, the preparation method of the medicine of above-mentioned treatment hepatitis can be that major ingredient and one of adjuvant are adopted traditional technology refining, also can be that major ingredient and adjuvant are separately refined and taken simultaneously with pill and decoction respectively.In mode three is that example describes:
The preparation of this medicine and instructions of taking can be the Rhizoma Atractylodis Macrocephalae, Herba Artemisiae Scopariae, Pericarpium Citri Reticulatae Viride, Polyporus, Medulla Tetrapanacis, Radix Glycyrrhizae, Radix Gentianae, Radix Ophiopogonis and Spora Lygodii to be added decocting by said ratio make decoction, and Melanteritum, Fructus Jujubae, Mel are made pill by said ratio; When taking, decoction and pill that above-mentioned weight portion is made are divided into three parts, once take a decoction and pill, and three times on the one, and decoction and pill are taken simultaneously.Perhaps be prepared as follows:
With the Rhizoma Atractylodis Macrocephalae 15～20g, Herba Artemisiae Scopariae 20～25g, Pericarpium Citri Reticulatae Viride 15～20g, Polyporus 10～20g, Medulla Tetrapanacis 10～15g, Radix Glycyrrhizae 10～15g, Radix Gentianae 10～15g, Radix Ophiopogonis 6～10 and Spora Lygodii 10～15g decoct with water;
In decocting the concentrated solution that after-filtration goes out, allocate Melanteritum 5～8g, enucleation into and fry Fructus Jujubae 5～8g after doing, and Mel 5～8g mf mass pil.
The medicine of above-mentioned listed treatment hepatitis all has better curative effect to various hepatitis, can repair the hepatocyte of damage, especially hepatitis B, icterohepatitis and liver cirrhosis is had tangible alleviation and therapeutical effect.In to numerous hepatopaths' tracking treatment, cure rate reaches more than 85%, and healing time is short, and can cure a general course of treatment, two to three courses of treatment at most, and do not need in the therapeutic process to take his medicine, cost is low.
Specific embodiment
Below in conjunction with Figure of description the specific embodiment of the present invention is done detailed description.
Embodiment one
Choose raw material: Rhizoma Atractylodis Macrocephalae 18g, Herba Artemisiae Scopariae 22g, Pericarpium Citri Reticulatae Viride 18g, Polyporus 15, Medulla Tetrapanacis 12g, Radix Glycyrrhizae 12g.Then this raw material is put into marmite and add 2 liters of clean waters, slow fire is made decoction after decocting 1～2 hour, and this decoction is divided into three parts, takes portion at every turn, and three times on the one, be a course of treatment January.
Application example:
Wang Jiangxia, the man, 25 years old, anorexia, weak, complexion yellowish-brown simple and unadorned, color of the lip is dark violet, the County Hospital laboratory test report shows suffers from chronic hepatitis, goes home with above-mentioned treatment by Chinese herbs, and behind the first quarter moon, above-mentioned symptom fades away, cure after the course of treatment, chemical examination once more, laboratory test report shows that liver function recovery is normal.
Sun Chongsheng, man, 32 years old, suffer from acute icterohepatitisshock, extremely weak, the mobility of thrombinogen is lower than 40%, serum bilirubin and alaninyl transferring enzyme height, behind above-mentioned treatment by Chinese herbs first quarter moon, weak symptom disappears substantially, can work, after the course of treatment full of physical strengthly, the mobility of thrombinogen, serum bilirubin and alaninyl transferring enzyme all recover normal value, no longer recurrence after the healing.
Zhang Guifu, man, 48 years old, suffering from liver cirrhosis, xerosis cutis is coarse, and complexion is gloomy, and vomiting and diarrhoea arranged, even be unable to leave the bed, with above-mentioned Chinese medicine continued treatment, spirit takes a turn for the better behind the first quarter moon, the state of an illness is obviously suppressed after the course of treatment, and can do some daily housework, recover after two courses of treatment to cure after three courses of treatment as ordinary person.
Embodiment two
Choose raw material, Melanteritum 8g, the Fructus Jujubae 8g after doing, Mel 8g are fried in enucleation.These three kinds of raw materials are mixed make pill, be divided into three parts, once a, three times on the one, be a course of treatment January.
Yu Shuzhen, the woman, 35 years old, suffer from chronic hepatitis, to cure after a course of treatment with above-mentioned Chinese medicine continued treatment, liver function recovery is normal.
Piao Ning, the man, 40 years old, suffer from acute icterohepatitisshock, the mobility of thrombinogen is lower than 40%, and serum bilirubin and alaninyl transferring enzyme height are with after above-mentioned treatment by Chinese herbs course of treatment, the mobility of thrombinogen, serum bilirubin and alaninyl transferring enzyme all recover normal value, no longer recurrence after the healing.
Liu Li, the woman, 45 years old, suffering from liver cirrhosis continued to cure with after above-mentioned treatment by Chinese herbs March, and liver function recovery is normal.
Embodiment three
Choose raw material, Rhizoma Atractylodis Macrocephalae 15g, Herba Artemisiae Scopariae 20g, Pericarpium Citri Reticulatae Viride 15g, Polyporus 10g, Medulla Tetrapanacis 10g, Radix Glycyrrhizae 10g, Melanteritum 5g, the Fructus Jujubae 5g after doing, Mel 5g are fried in enucleation.The Rhizoma Atractylodis Macrocephalae, Herba Artemisiae Scopariae, Pericarpium Citri Reticulatae Viride, Polyporus, Medulla Tetrapanacis, Radix Glycyrrhizae, Melanteritum and Fructus Jujubae are added 2 liters of clean waters, and slow fire is made decoction after decocting 1～2 hour, will add Mel in this decoction, is divided into three parts, takes portion at every turn, and three times on the one, be a course of treatment January.
Application example:
Wang Yajiang, the man, 23 years old, suffer from hepatitis B, check result is a great three positive, cardinal symptom shows as immune system disorder, cures after two courses of treatment and protection antibody occurs with above-mentioned Chinese medicine continued treatment.
Embodiment four
Choose raw material, Rhizoma Atractylodis Macrocephalae 15g, Herba Artemisiae Scopariae 20g, Pericarpium Citri Reticulatae Viride 15g, Polyporus 10g, Medulla Tetrapanacis 10g, Radix Glycyrrhizae 10g, Melanteritum 5g, the Fructus Jujubae 5g after doing, Mel 5g are fried in enucleation.The Rhizoma Atractylodis Macrocephalae, Herba Artemisiae Scopariae, Pericarpium Citri Reticulatae Viride, Polyporus, Medulla Tetrapanacis and Radix Glycyrrhizae are added 2 liters of clean waters, and slow fire is made decoction after decocting 1～2 hour; And make pill with Mel, Melanteritum and Fructus Jujubae three, and this decoction and pill are divided into three parts, take portion, and decoction and pill take simultaneously at every turn, three times on the one, be a course of treatment January.
Sun Liquan, the man, 17 years old, suffer from hepatitis B, check result is a small three positive, cardinal symptom shows as immune system disorder, retarded growth, cures after two courses of treatment and protection antibody occurs with above-mentioned Chinese medicine continued treatment.
What deserves to be explained is, in the present embodiment, also the Rhizoma Atractylodis Macrocephalae, Herba Artemisiae Scopariae, Pericarpium Citri Reticulatae Viride, Polyporus, Medulla Tetrapanacis and Radix Glycyrrhizae can be decocted with water; In the concentrated solution that the decoction after-filtration goes out, allocate Melanteritum, Fructus Jujubae then into, reach Mel with mf mass pil, consistent when consumption is taken simultaneously with above-mentioned decoction and pill, the drug effect unanimity.
Embodiment five
Choose raw material: Rhizoma Atractylodis Macrocephalae 20g: Herba Artemisiae Scopariae 25g: Pericarpium Citri Reticulatae Viride 20g: Polyporus 20g: Medulla Tetrapanacis 15g: Radix Glycyrrhizae 15g: Radix Gentianae 15g: Radix Ophiopogonis 10g: Spora Lygodii 15g.Above-mentioned raw materials is added in the marmite, add and make decoction after warm fire decocts 1～2 hour behind 2 liters in the water, this decoction is divided into three parts, take portion at every turn, three times on the one, be a course of treatment January.
Application example
Ge Fei, the man, 28 years old, suffer from hepatitis C, cardinal symptom has: detest oil, inappetence, weak, lazy moving, low grade fever, cure after taking a course of treatment with above-mentioned Chinese medicine.
This medicine is particularly remarkable to the effect of treatment acute icterohepatitis:
Song Ping, the man, 35 years old, suffer from acute icterohepatitisshock, the mobility of thrombinogen is lower than 40%, and serum bilirubin and alaninyl transferring enzyme height are with after above-mentioned treatment by Chinese herbs half course of treatment, the mobility of thrombinogen, serum bilirubin and alaninyl transferring enzyme all recover normal value, no longer recurrence after the healing.
Embodiment six
Choose raw material: Melanteritum 8g, the Fructus Jujubae 8g after doing, Mel 8g, Radix Gentianae 15g, Radix Ophiopogonis 10g, Spora Lygodii 15g are fried in enucleation.These three kinds of raw materials are mixed make pill, be divided into three parts, once a, three times on the one, be a course of treatment January.
Wang Ying, the woman, 36 years old, suffer from hepatitis A, symptoms such as fear of cold, heating, stomachache, diarrhoea, dyspepsia, loss of appetite, nauseating, tired, hepatomegaly and abnormal liver function are arranged, cure after taking a course of treatment with above-mentioned Chinese medicine.
Embodiment seven
Choose raw material: Rhizoma Atractylodis Macrocephalae 15g, Herba Artemisiae Scopariae 20g, Pericarpium Citri Reticulatae Viride 15g, Polyporus 10g, Medulla Tetrapanacis 10g, Radix Glycyrrhizae 10g, Radix Gentianae 10g, Radix Ophiopogonis 6g, Spora Lygodii 10g, Melanteritum 8g, the Fructus Jujubae 8g after doing, Mel 8g are fried in enucleation.Above-mentioned raw materials is added in the marmite, add and make decoction after warm fire decocts 1～2 hour behind 2 liters in the water, this decoction is divided into three parts, take portion at every turn, three times on the one, be a course of treatment January.
Application example
Wu Yang, the man, 53 years old, suffer from chronic hepatitis, cure the disease and do not heal for many years, the state of an illness repeatedly, and the time outbreak is arranged, thoroughly cure after taking two courses of treatment with above-mentioned Chinese medicine, after no longer recurrence.
This medicine is particularly remarkable to the therapeutic effect of liver cirrhosis:
Wang Tao, the man, 48 years old, suffering from liver cirrhosis was unable to leave the bed, and promptly cured two courses of treatment with above-mentioned Chinese medicine continued treatment, and liver function recovery is normal.
What deserves to be explained is, in the present embodiment, can be the Rhizoma Atractylodis Macrocephalae, Herba Artemisiae Scopariae, Pericarpium Citri Reticulatae Viride, Polyporus, Medulla Tetrapanacis, Radix Glycyrrhizae, Radix Gentianae, Radix Ophiopogonis and Spora Lygodii to be added decocting by said ratio make decoction, and Melanteritum, Fructus Jujubae, Mel are made pill by said ratio; When taking, decoction and pill that above-mentioned weight portion is made are divided into three parts, once take a decoction and pill, and three times on the one, and decoction and pill are taken simultaneously.Or:
The Rhizoma Atractylodis Macrocephalae, Herba Artemisiae Scopariae, Pericarpium Citri Reticulatae Viride, Polyporus, Medulla Tetrapanacis, Radix Glycyrrhizae, Radix Gentianae, Radix Ophiopogonis and Spora Lygodii are decocted with water; In the concentrated solution that the decoction after-filtration goes out, allocate Melanteritum, Fructus Jujubae then into, reach Mel with mf mass pil, consistent when consumption is taken simultaneously with above-mentioned decoction and pill, the drug effect unanimity.
Each embodiment to sum up, this medicine of the medicine of treatment hepatitis provided by the invention all has better curative effect to various hepatitis, can repair the hepatocyte of damage, especially hepatitis B, icterohepatitis and liver cirrhosis is had tangible alleviation and therapeutical effect.In to numerous hepatopaths' tracking treatment, cure rate reaches more than 85%, and healing time is short, and can cure a general course of treatment, two to three courses of treatment at most, and do not need in the therapeutic process to take his medicine, cost is low.Because the restriction of length, the present invention do not exemplify one by one to numerous healing patients' situation separately, only with above-mentioned application example as an illustration.
More than; only be preferred embodiment of the present invention, but protection scope of the present invention is not limited thereto, anyly is familiar with those skilled in the art in the technical scope that the present invention discloses; the variation that can expect easily or replacement all should be encompassed within protection scope of the present invention.Therefore, protection scope of the present invention should be as the criterion with the protection domain that claim was defined.
Claims (10)
1. a medicine for the treatment of hepatitis is characterized in that, its dosage form comprises decoction, electuary, pill, unguentum, powder, is mainly made by following proportion raw material:
The Rhizoma Atractylodis Macrocephalae 15～20g: Herba Artemisiae Scopariae 20～25g: Pericarpium Citri Reticulatae Viride 15～20g: Polyporus 10～20g: Medulla Tetrapanacis 10～15g: Radix Glycyrrhizae 10～15g.
2. the medicine of treatment hepatitis according to claim 1 is characterized in that, the raw material of this medicine also comprises Melanteritum, Fructus Jujubae and Mel, and each proportion of raw materials is as follows:
The Rhizoma Atractylodis Macrocephalae 15～20g: Herba Artemisiae Scopariae 20～25g: Pericarpium Citri Reticulatae Viride 15～20g: Polyporus 10～20g: Medulla Tetrapanacis 10～15g: Radix Glycyrrhizae 10～15g: Melanteritum 5～8g: the Fructus Jujubae 5～8g after doing is fried in enucleation: Mel 5～8g.
3. the medicine of treatment hepatitis according to claim 1 is characterized in that, the raw material of this medicine also comprises Radix Gentianae, Radix Ophiopogonis and Spora Lygodii, and each proportion of raw materials is as follows:
The Rhizoma Atractylodis Macrocephalae 15～20g: Herba Artemisiae Scopariae 20～25g: Pericarpium Citri Reticulatae Viride 15～20g: Polyporus 10～20g: Medulla Tetrapanacis 10～15g: Radix Glycyrrhizae 10～15g: Radix Gentianae 10～15g: Radix Ophiopogonis 6～10g: Spora Lygodii 10～15g.
4. the medicine of treatment hepatitis according to claim 1 is characterized in that, the raw material of this medicine also comprises Melanteritum, Fructus Jujubae, Mel, Radix Gentianae, Radix Ophiopogonis and Spora Lygodii, and each proportion of raw materials is as follows:
The Rhizoma Atractylodis Macrocephalae 15～20g: Herba Artemisiae Scopariae 20～25g: Pericarpium Citri Reticulatae Viride 15～20g: Polyporus 10～20g: Medulla Tetrapanacis 10～15g: Radix Glycyrrhizae 10～15g: Radix Gentianae 10～15g: Radix Ophiopogonis 6～10g: Spora Lygodii 10～15g: Melanteritum 5～8g: the Fructus Jujubae 5～8g after doing is fried in enucleation: Mel 5～8g.
5. the medicine of treatment hepatitis according to claim 4 is characterized in that, its preparation method is as follows:
With the Rhizoma Atractylodis Macrocephalae 15～20g, Herba Artemisiae Scopariae 20～25g, Pericarpium Citri Reticulatae Viride 15～20g, Polyporus 10～20g, Medulla Tetrapanacis 10～15g, Radix Glycyrrhizae 10～15g, Radix Gentianae 10～15g, Radix Ophiopogonis 6～10 and Spora Lygodii 10～15g decoct with water;
In decocting the concentrated solution that after-filtration goes out, allocate Melanteritum 5～8g, enucleation into and fry Fructus Jujubae 5～8g after doing, and Mel 5～8g mf mass pil.
6. a medicine for the treatment of hepatitis is characterized in that, its dosage form comprises decoction, electuary, pill, unguentum, powder, is mainly made by following proportion raw material:
Melanteritum 5～8g: the Fructus Jujubae 5～8g after doing is fried in enucleation: Mel 5～8g.
7. the medicine of treatment hepatitis according to claim 6 is characterized in that, its raw material also comprises the Rhizoma Atractylodis Macrocephalae, Herba Artemisiae Scopariae, Pericarpium Citri Reticulatae Viride, Polyporus, Medulla Tetrapanacis and Radix Glycyrrhizae, and each proportion of raw materials is as follows:
Melanteritum 5～8g: the Fructus Jujubae 5～8g after doing is fried in enucleation: Mel 5～8g: the Rhizoma Atractylodis Macrocephalae 15～20g: Herba Artemisiae Scopariae 20～25g: Pericarpium Citri Reticulatae Viride 15～20g: Polyporus 10～20g: Medulla Tetrapanacis 10～15g: Radix Glycyrrhizae 10～15g.
8. the medicine of treatment hepatitis according to claim 6 is characterized in that, the raw material of this medicine also comprises Radix Gentianae, Radix Ophiopogonis and Spora Lygodii, and each proportion of raw materials is as follows:
Melanteritum 5～8g: the Fructus Jujubae 5～8g after doing is fried in enucleation: Mel 5～8g: Radix Gentianae 10～15g: Radix Ophiopogonis 6～10g: Spora Lygodii 10～15g.
9. the medicine of treatment hepatitis according to claim 6 is characterized in that, the raw material of this medicine also comprises Melanteritum, Fructus Jujubae, Mel, Radix Gentianae, Radix Ophiopogonis and Spora Lygodii, and each proportion of raw materials is as follows:
Melanteritum 5～8g: the Fructus Jujubae 5～8g after doing is fried in enucleation: Mel 5～8g: the Rhizoma Atractylodis Macrocephalae 15～20g: Herba Artemisiae Scopariae 20～25g: Pericarpium Citri Reticulatae Viride 15～20g: Polyporus 10～20g: Medulla Tetrapanacis 10～15g: Radix Glycyrrhizae 10～15g: Radix Gentianae 10～15g: Radix Ophiopogonis 6～10g: Spora Lygodii 10～15g.
10. the medicine of treatment hepatitis according to claim 9 is characterized in that, its preparation method is as follows:
With the Rhizoma Atractylodis Macrocephalae 15～20g, Herba Artemisiae Scopariae 20～25g, Pericarpium Citri Reticulatae Viride 15～20g, Polyporus 10～20g, Medulla Tetrapanacis 10～15g, Radix Glycyrrhizae 10～15g, Radix Gentianae 10～15g, Radix Ophiopogonis 6～10 and Spora Lygodii 10～15g decoct with water;
In decocting the concentrated solution that after-filtration goes out, allocate Melanteritum 5～8g, enucleation into and fry Fructus Jujubae 5～8g after doing, and Mel 5～8g mf mass pil.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101065880A CN101757203B (en) | 2009-07-06 | 2010-02-05 | Medicament for treating hepatitis |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910158315.8 | 2009-07-06 | ||
| CN200910158315 | 2009-07-06 | ||
| CN2010101065880A CN101757203B (en) | 2009-07-06 | 2010-02-05 | Medicament for treating hepatitis |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012100387509A Division CN102526256B (en) | 2010-02-05 | 2010-02-05 | Medicine for treating hepatitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101757203A true CN101757203A (en) | 2010-06-30 |
| CN101757203B CN101757203B (en) | 2012-04-11 |
Family
ID=42488685
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010101065880A Expired - Fee Related CN101757203B (en) | 2009-07-06 | 2010-02-05 | Medicament for treating hepatitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101757203B (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102138995A (en) * | 2010-11-18 | 2011-08-03 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating chronic hepatitis |
| CN102698194A (en) * | 2012-06-07 | 2012-10-03 | 黄芸 | Virgate wormwood herb Chinese medicinal oral liquid for treating chronic hepatitis and preparation method |
| CN104840730A (en) * | 2015-06-01 | 2015-08-19 | 青岛友诚高新技术有限公司 | Pure traditional Chinese medicine preparation for treating hepatitis and preparation method thereof |
| CN108371702A (en) * | 2018-05-08 | 2018-08-07 | 耿全好 | A kind of drug for the liver cell that can repair damage |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102526256B (en) * | 2010-02-05 | 2013-07-10 | 孙敦军 | Medicine for treating hepatitis |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100384467C (en) * | 2006-08-07 | 2008-04-30 | 张庆存 | Traditional Chinese medicine composition for treating hepatitis and fatty liver |
-
2010
- 2010-02-05 CN CN2010101065880A patent/CN101757203B/en not_active Expired - Fee Related
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102138995A (en) * | 2010-11-18 | 2011-08-03 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating chronic hepatitis |
| CN102698194A (en) * | 2012-06-07 | 2012-10-03 | 黄芸 | Virgate wormwood herb Chinese medicinal oral liquid for treating chronic hepatitis and preparation method |
| CN102698194B (en) * | 2012-06-07 | 2013-11-27 | 黄芸 | Virgate wormwood herb Chinese medicinal oral liquid for treating chronic hepatitis and preparation method |
| CN104840730A (en) * | 2015-06-01 | 2015-08-19 | 青岛友诚高新技术有限公司 | Pure traditional Chinese medicine preparation for treating hepatitis and preparation method thereof |
| CN108371702A (en) * | 2018-05-08 | 2018-08-07 | 耿全好 | A kind of drug for the liver cell that can repair damage |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101757203B (en) | 2012-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100496586C (en) | Medicinal liquor for treating hyperosteogeny and lumbar intervertebral disc protrusion | |
| CN101095747A (en) | Chinese medicine for treating various toothaches | |
| CN101757203B (en) | Medicament for treating hepatitis | |
| CN101129593A (en) | Traditional Chinese medicine for treating senile habitual constipation | |
| CN101152331A (en) | Traditional Chinese medicine for treating qi deficiency type haemorrhoid hemorrhage | |
| CN104383496A (en) | Drug for treating acute or chronic gastroenteritis | |
| CN101168038A (en) | Traditional Chinese medicine for treating biliary ascariasis | |
| CN101129966A (en) | Traditional Chinese medicine for treating hyperthyroidism accompanied by diarrhea | |
| CN102526256B (en) | Medicine for treating hepatitis | |
| CN101164611A (en) | Traditional Chinese medicine for treating cold pathogen lung-attacking type pertussis | |
| CN101152337A (en) | Traditional Chinese medicine for treating tinnitus caused by hyperactivity of liver-fire and gallbladder-fire | |
| CN101152519A (en) | Traditional Chinese medicine for treating pregnancy-induced hypertension syndrome | |
| CN101129967A (en) | Traditional Chinese medicine for treating diabetic diarrhea | |
| CN103705578B (en) | There is blood fat reducing and Chinese medicine preparation suppressing blood glucose rising effect and preparation method thereof | |
| CN101152352A (en) | Traditional Chinese medicine for treating intestinal abscess | |
| CN101152524A (en) | Traditional Chinese medicine for treating infantile chronic bacillary dysentery | |
| CN104435125A (en) | Traditional Chinese medicine composition preparation for treating viral hepatitis | |
| CN101152313A (en) | Traditional Chinese medicine for treating summer dermatitis | |
| CN101152387A (en) | Traditional Chinese medicine for treating infantile autumn diarrhea | |
| CN101129519A (en) | Traditional Chinese medicine for treating chronic diarrhea | |
| CN101134077A (en) | Traditional Chinese medicine for treating Meniere's syndrome | |
| CN102743658B (en) | Traditional Chinese medicinal composition for treating urticaria | |
| CN101152404A (en) | Traditional Chinese medicine for treating filariasis chyluria | |
| CN101143205A (en) | Traditional Chinese medicine for treating fever due to qi deficiency | |
| CN101130003A (en) | Traditional Chinese medicine for treating acute cholecystitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120411 Termination date: 20180205 |